|Bid||14.85 x 0|
|Ask||15.25 x 0|
|Day's Range||14.61 - 15.35|
|52 Week Range||3.79 - 16.24|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 08, 2022 - Nov 14, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||15.93|
LAVAL, Quebec, August 10, 2022--BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) ("BELLUS Health" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough ("RCC") and other cough hypersensitivity indications, today reported its financial and operating results for the second quarter ending June 30, 2022.
Brookfield Renewable Partners L.P. (T.BEP.UN) hit a new 52-week high of $51.77 Monday. No news stories ...
Investing, even if you have minimal capital to invest with, is a good habit. It prevents your savings (in cash) from inflation-driven depreciation. The post 3 Simple TSX Stocks to Buy With $25 Right Now appeared first on The Motley Fool Canada.